Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 125.3
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Parnax Lab Ltd. engages in manufacturing and trading of pharmaceuticals and medicinal products. It offers liquid products, ointments, gels, creams, tablets and capsules. The company was founded on August 3, 1982 and is headquartered in Mumbai, India.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap'
Data is available to registered users only
Buy
Sell